• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者 CD8 T 细胞应答特征。

The characterization of CD8 T-cell responses in COVID-19.

机构信息

Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

出版信息

Emerg Microbes Infect. 2024 Dec;13(1):2287118. doi: 10.1080/22221751.2023.2287118. Epub 2024 Jan 11.

DOI:10.1080/22221751.2023.2287118
PMID:37990907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10786432/
Abstract

This review gives an overview of the protective role of CD8 T cells in SARS-CoV-2 infection. The cross-reactive responses intermediated by CD8 T cells in unexposed cohorts are described. Additionally, the relevance of resident CD8 T cells in the upper and lower airway during infection and CD8 T-cell responses following vaccination are discussed, including recent worrisome breakthrough infections and variants of concerns (VOCs). Lastly, we explain the correlation between CD8 T cells and COVID-19 severity. This review aids in a deeper comprehension of the association between CD8 T cells and SARS-CoV-2 and broadens a vision for future exploration.

摘要

本文综述了 CD8 T 细胞在 SARS-CoV-2 感染中的保护作用。描述了未暴露人群中 CD8 T 细胞介导的交叉反应性应答。此外,还讨论了感染期间上呼吸道和下呼吸道中驻留 CD8 T 细胞以及接种疫苗后的 CD8 T 细胞反应的相关性,包括最近令人担忧的突破性感染和关注的变异株(VOCs)。最后,我们解释了 CD8 T 细胞与 COVID-19 严重程度之间的相关性。本文有助于更深入地理解 CD8 T 细胞与 SARS-CoV-2 的关联,并为未来的探索提供了更广阔的视野。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482f/10786432/668dce14ba41/TEMI_A_2287118_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482f/10786432/eac04e001e55/TEMI_A_2287118_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482f/10786432/668dce14ba41/TEMI_A_2287118_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482f/10786432/eac04e001e55/TEMI_A_2287118_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482f/10786432/668dce14ba41/TEMI_A_2287118_F0002_OC.jpg

相似文献

1
The characterization of CD8 T-cell responses in COVID-19.新型冠状病毒肺炎患者 CD8 T 细胞应答特征。
Emerg Microbes Infect. 2024 Dec;13(1):2287118. doi: 10.1080/22221751.2023.2287118. Epub 2024 Jan 11.
2
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
3
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity.疫苗接种者中的 SARS-CoV-2 突破感染诱导广泛特异性的病毒特异性鼻驻留 CD8+和 CD4+T 细胞。
J Exp Med. 2022 Oct 3;219(10). doi: 10.1084/jem.20220780. Epub 2022 Aug 16.
4
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.既往常见人冠状病毒暴露对 mRNA 疫苗接种后 SARS-CoV-2 特异性 T 细胞和记忆 B 细胞应答的影响。
Viruses. 2023 Feb 24;15(3):627. doi: 10.3390/v15030627.
5
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
6
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.采用 ex vivo ELISpot assay 检测 COVID-19 恢复期患者和未接触者的 SARS-CoV-2 特异性 T 细胞免疫。
Clin Microbiol Infect. 2021 Jul;27(7):1029-1034. doi: 10.1016/j.cmi.2021.03.010. Epub 2021 Apr 2.
7
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.SARS-CoV-2 的免疫原性 T 细胞表位可被未暴露个体的循环记忆和幼稚 CD8 T 细胞识别。
EBioMedicine. 2021 Oct;72:103610. doi: 10.1016/j.ebiom.2021.103610. Epub 2021 Oct 6.
8
T Cell Responses to SARS-CoV-2.T细胞对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的反应。
Annu Rev Immunol. 2023 Apr 26;41:343-373. doi: 10.1146/annurev-immunol-101721-061120. Epub 2023 Feb 7.
9
Cross-reactive humoral and CD4 T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.哥伦比亚人群中对 Mu 和 Gamma SARS-CoV-2 变体的交叉反应性体液和 CD4 T 细胞应答。
Front Immunol. 2023 Jul 27;14:1241038. doi: 10.3389/fimmu.2023.1241038. eCollection 2023.
10
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.SARS-CoV-2 疫苗接种可引发以 CD8 T 细胞为主的肝炎。
J Hepatol. 2022 Sep;77(3):653-659. doi: 10.1016/j.jhep.2022.03.040. Epub 2022 Apr 21.

引用本文的文献

1
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
2
Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity.使用人类益生菌孢子作为佐剂的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的黏膜疫苗可诱导强大的全身和黏膜免疫。
Vaccines (Basel). 2025 Jul 21;13(7):772. doi: 10.3390/vaccines13070772.
3
CD31 + naïve T cells associate with immunosenescence and responsiveness to multiple vaccines in older adults.

本文引用的文献

1
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.COVID-19 恢复期患者中针对 II 型肺泡细胞抗原的自身反应性 T 细胞。
J Autoimmun. 2023 Nov;140:103118. doi: 10.1016/j.jaut.2023.103118. Epub 2023 Oct 10.
2
Multimodal single-cell datasets characterize antigen-specific CD8 T cells across SARS-CoV-2 vaccination and infection.多模态单细胞数据集描绘了 SARS-CoV-2 疫苗接种和感染过程中抗原特异性 CD8 T 细胞的特征。
Nat Immunol. 2023 Oct;24(10):1725-1734. doi: 10.1038/s41590-023-01608-9. Epub 2023 Sep 21.
3
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study.
CD31+初始T细胞与老年人的免疫衰老及对多种疫苗的反应性相关。
Immun Ageing. 2025 Mar 8;22(1):10. doi: 10.1186/s12979-025-00504-0.
4
Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge.奥密克戎毒株流行期间接受阿兹夫定治疗的新冠患者的免疫表型特征及临床结局
Front Immunol. 2024 Nov 25;15:1465238. doi: 10.3389/fimmu.2024.1465238. eCollection 2024.
5
The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease.缺铁和高铁饮食对新型冠状病毒肺炎肺部感染及疾病的影响。
Front Microbiol. 2024 Sep 4;15:1441495. doi: 10.3389/fmicb.2024.1441495. eCollection 2024.
6
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.HIV感染者中新冠病毒突破性感染的相关因素:加拿大卫生研究院临床研究网络328研究结果
Vaccines (Basel). 2024 Apr 23;12(5):447. doi: 10.3390/vaccines12050447.
7
A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.SARS-CoV-2 变体中 T 细胞表位多样性的生物信息学分析:与美国人群中 COVID-19 临床严重程度的关联。
Front Immunol. 2024 May 9;15:1357731. doi: 10.3389/fimmu.2024.1357731. eCollection 2024.
8
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia.SARS-CoV-2蛋白亚单位重组疫苗(CoV2-IB 0322)在印度尼西亚一项3期试验子研究中的免疫原性评估。
Vaccines (Basel). 2024 Apr 1;12(4):371. doi: 10.3390/vaccines12040371.
新冠病毒感染后自身免疫性疾病的风险及疫苗接种的潜在保护作用:一项基于人群的队列研究
EClinicalMedicine. 2023 Aug 16;63:102154. doi: 10.1016/j.eclinm.2023.102154. eCollection 2023 Sep.
4
COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms.COVID-19 诱导的自身免疫性甲状腺炎:探索分子机制。
J Med Virol. 2023 Aug;95(8):e29001. doi: 10.1002/jmv.29001.
5
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting.由 COVID-19 感染引发的强直性脊柱炎自身反应性 T 细胞:免疫宿主防御和自身免疫印记的快照。
Autoimmun Rev. 2023 Sep;22(9):103392. doi: 10.1016/j.autrev.2023.103392. Epub 2023 Jul 15.
6
The unreversible reduced but persistent activated NK and CD8 T cells in severe/critical COVID-19 during omicron pandemic in China.中国奥密克戎流行期间,重症/危重症 COVID-19 患者体内持续存在但不可逆转减少的活化 NK 和 CD8 T 细胞。
Emerg Microbes Infect. 2023 Dec;12(1):2208679. doi: 10.1080/22221751.2023.2208679.
7
Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases.Covid-19 是自身免疫性和多种炎症性疾病的诱发因素。
Life Sci. 2023 Apr 15;319:121531. doi: 10.1016/j.lfs.2023.121531. Epub 2023 Feb 27.
8
Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV.mRNA 疫苗接种后对关注的 SARS-CoV-2 变异株的 T 细胞反应降低与 HIV 感染者突破性感染的风险。
AIDS. 2023 May 1;37(6):877-882. doi: 10.1097/QAD.0000000000003504. Epub 2023 Feb 7.
9
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.与未接种疫苗者相比,AZD1222 可引发强烈的体液和细胞回忆应答,从而减弱突破性 SARS-CoV-2 感染。
Front Immunol. 2023 Jan 13;13:1062067. doi: 10.3389/fimmu.2022.1062067. eCollection 2022.
10
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.先前感染 SARS-CoV-2 和混合免疫对奥密克戎变异株和重症疾病的保护效力:系统评价和荟萃回归分析。
Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18.